ALNY: Wutah pendapatan triwulanan Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY) - logo korporat

Alnylam Pharmaceuticals is managed by experts in bringing orphan drugs to market. Revenues are based on RNA interference for the therapy of genetic defects. Stability is ensured by patent protection coupled with strict control over testing costs. The history of quarterly revenue dynamics confirms the business's resilience to shocks, with the value holding at 17.00, allowing for an assessment of the company's strength.

ALNY Tambahing pendapatan triwulanan Alnylam Inc. (04.07.2022 - 21.11.2026)

Ringkesan rincian data analitis Alnylam (ALNY)

Analisis kabeh metrik perusahaan:ALNY - Alnylam Pharmaceuticals
Produk sing diprodhuksi alnylam.com

Quarterly revenue growth measures the percentage change in sales volume compared to the previous period, reflecting the current pace of business expansion. For Alnylam Pharmaceuticals (ALNY), this momentum is sustained by a unique monopoly in the field of RNA interference and high barriers to entry. By analyzing the QoQ revenue growth rate, an investor can assess the effectiveness of drug commercialization. Stable positive dynamics confirm the fundamental resilience of Alnylam Pharmaceuticals (ALNY) in the market.

Analisis pesaing Alnylam Pharmaceuticals

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan INSM (Insmed Incorporated)|UTHR: Wutah pendapatan triwulanan|BioMarin Pharmaceutical Inc. (BMRN) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BridgeBio Pharma Inc|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)